Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.850
-0.005 (-0.18%)
Jul 18, 2025, 12:42 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €221.30 million as of July 18, 2025. Its market cap has increased by 101.50% in one year.
Market Cap
221.30M
Enterprise Value
231.89M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.85
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 221.30M, an increase of 81.39%. That is a compound annual growth rate of 6.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.11B |
| Laboratorios Farmaceuticos Rovi | 2.79B |
| Almirall | 2.37B |
| Pharma Mar | 1.42B |
| Faes Farma | 1.41B |
| Clínica Baviera | 701.05M |
| Laboratorio Reig Jofre | 242.52M |
| Atrys Health | 223.20M |